Immix Biopharma, Inc. (IMMX) - Latest Market Data

Price & Market Data

Price: $10.66

Daily Change: +$0.74 / 6.94%

Daily Range: $9.58 - $10.77

Market Cap: $580,025,792

Daily Volume: 863,814

Performance Metrics

1 Week: 11.51%

1 Month: 10.01%

3 Months: 58.40%

6 Months: 238.4%

1 Year: 410.1%

YTD: 103.8%

About Immix Biopharma, Inc. (IMMX)

Discover the market dynamics of Immix Biopharma, Inc. (IMMX). The stock stands at 10.66, with its daily performance showing a change of +$0.74 / 6.94%. Its market cap is valued at 580,025,792. Explore its 6-month (238.4%) and 1-week (11.51%) performance for a quick overview.

Company Details

Employees: 21

Sector: Health technology

Industry: Pharmaceuticals: major

Country: United States

Details

Immix Biopharma, Inc., a clinical-stage biopharmaceutical company, engages in the development of chimeric antigen receptor cell therapy in light chain Amyloidosis and immune-mediated diseases in the United States and Australia. The company' lead product is NXC-201 for relapsed/refractory AL Amyloidos. Immix Biopharma, Inc., was incorporated in 2012 and is headquartered in Los Angeles, California.

Selected stocks

Northeast Bank (NBN)

Apogee Therapeutics, Inc. (APGE)

HF Foods Group Inc. (HFFG)

Abacus Global Management, Inc. (ABX)